2016 interim results show signs that management’s pursuit of growth via a global sales model is beginning to deliver results, as interim results are in line with our expectations. Exports now account for 43% of LiDCO product sales with comparative H1-16 revenues up 10% to £3.1m (H1-15 of £2.8m). US revenues grew 37% whilst UK sales grew 1% (disposables units up 13%). Of note was the publication of numerous independent surgical trials in leading surgical journals demonstratin ....